TCT-92 Randomized Comparison of Ridaforolimus- and Zotarolimus-Eluting Coronary Stents: 2-Year Clinical Outcomes of the Pooled BIONICS and NIREUS Trials

Authors :: David E. Kandzari
M. Ozgu Ozan
Martin B. Leon
Mengdan Liu
Maayan Konigstein
Gregg W. Stone
Ori Ben-Yehuda
Yoram Richter
Pieter C. Smits
Source :: Journal of the American College of Cardiology. 72:B40
Publication Year :: 2018
Publisher :: Elsevier BV, 2018.
Abstract: In the BioNIR Ridaforolimus-Eluting Coronary Stent System in Coronary Stenosis (BIONICS) and the NIREUS trials, the safety and efficacy of the novel ridaforolimus-eluting stent (RES) was evaluated, demonstrating the noninferiority of this stent in comparison to zotarolimus-eluting stent (ZES), in

Subjects :: medicine.medical_specialty
business.industry
medicine.medical_treatment
Stent
Coronary stenosis
equipment and supplies
Ridaforolimus
chemistry.chemical_compound
surgical procedures, operative
chemistry
Coronary stent
medicine
Zotarolimus
cardiovascular diseases
Radiology
Cardiology and Cardiovascular Medicine
business
medicine.drug

Full Text Access

Tools